2026-04-22 · HN #50028027
Clinical Trial Begins for First-in-Human Prion Disease Drug Targeting Protein Production
A phase 1 clinical trial has started enrolling patients to test a novel small interfering RNA drug designed to reduce the production of the prion protein responsible for fatal neurodegenerative disorders.
